B A R O S
Skip to main content

Baros Surgery

Procedure Overview

  • Procedure Type: Metabolic Surgery
  • Surgery Duration: 1–2.5 Hours
  • Resolution Time: 7 Days – 3 Months
  • Approach: Laparoscopic / Robotic
Metabolic Surgery

Resolving Type 2 Diabetes Through Surgical Intervention

Metabolic surgery is specifically designed to treat Type 2 diabetes and related metabolic conditions, even in patients who are not morbidly obese. Evidence accumulated over decades shows that metabolic surgery is the most effective therapy for diabetes mellitus, delivering up to 95% resolution of Type 2 diabetes in obese patients.

The Baros team at Apollo Hospitals is one of the leading centers for diabetic surgery in India. Procedures such as Ileal Interposition have shown strong results even in non-obese patients with BMI of 27.5 and above. Most patients see significant improvement in blood sugar control within 7 days to 3 months of surgery.

Metabolic surgery works by altering the gut-hormone axis, improving insulin sensitivity and glucose metabolism at a fundamental level. The procedure is not merely about weight loss — it addresses the root metabolic dysfunction that drives Type 2 diabetes, offering a pathway to long-term remission for eligible patients.

01. Who It's For

Metabolic surgery is recommended for patients with Type 2 diabetes who have not achieved adequate control through medication and lifestyle changes, with or without significant obesity.

  • Patients with uncontrolled Type 2 diabetes despite medication
  • Obese patients with BMI above 27.5 and metabolic syndrome
  • Patients with insulin resistance and multiple metabolic risk factors
  • Candidates where long-term medication has limited effectiveness

02. How It Works

Metabolic surgery modifies the gut-hormone signaling pathway to fundamentally reset insulin sensitivity and glucose metabolism, not merely restrict food intake.

03. Expected Outcomes

Metabolic surgery consistently delivers transformative results for Type 2 diabetes patients. Clinical outcomes at Baros Apollo include:

  • Up to 95% resolution of Type 2 diabetes in obese patients
  • Most patients see improvement within 7 days to 3 months
  • Significant reduction in diabetes medication or complete elimination
  • Improved cardiovascular health markers and overall metabolic profile